ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon PrintIcon Twitter
Business

Tianjin explosion hampers supplies of hepatitis-B drug in Japan

TOKYO -- British drugmaker GlaxoSmithKline has announced that the explosion that rocked Tianjin, China, on Aug. 12 has strained its supply of a hepatitis-B treatment marketed in Japan.

Sponsored Content

About Sponsored Content This content was commissioned by Nikkei's Global Business Bureau.

Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.

Celebrate our next chapter
Free access for everyone - Sep. 30

Find out more